RT Journal Article
SR Electronic
T1 Estimating the relative proportions of SARS-CoV-2 strains from wastewater samples
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.13.22269236
DO 10.1101/2022.01.13.22269236
A1 Lenore Pipes
A1 Zihao Chen
A1 Svetlana Afanaseva
A1 Rasmus Nielsen
YR 2022
UL http://medrxiv.org/content/early/2022/01/14/2022.01.13.22269236.abstract
AB Wastewater surveillance has become essential for monitoring the spread of SARS-CoV-2. The quantification of SARS-CoV-2 RNA in wastewater correlates with the Covid-19 caseload in a community. However, estimating the proportions of different SARS-CoV-2 strains has remained technically difficult. We present a method for estimating the relative proportions of SARS-CoV-2 strains from wastewater samples. The method uses an initial step to remove unlikely strains, imputation of missing nucleotides using the global SARS-CoV-2 phylogeny, and an Expectation-Maximization (EM) algorithm for obtaining maximum likelihood estimates of the proportions of different strains in a sample. Using simulations with a reference database of >3 million SARS-CoV-2 genomes, we show that the estimated proportions accurately reflect the true proportions given sufficiently high sequencing depth and that the phylogenetic imputation is highly accurate and substantially improves the reference database.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work used the Extreme Science and Engineering Discovery Environment (XSEDE) Bridges-2 system at the Pittsburgh Supercomputing Center through allocation BIO180028 and was supported by NIH grant 1R01GM138634-01.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSimulations used in this manuscript can be downloaded at https://doi.org/10.5281/zenodo.5838942. The imputed MSA can be downloaded at https://doi.org/10.5281/zenodo.5838946. Identical strains are contained in the headers of the MSA separated by colons. Software for the method is available for download at https://github.com/lpipes/SARS_CoV_2_wastewater_surveillance. https://doi.org/10.5281/zenodo.5838942 https://doi.org/10.5281/zenodo.5838946 https://github.com/lpipes/SARS_CoV_2_wastewater_surveillance